CorVel (CRVL) Competitors $86.52 -0.19 (-0.22%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$86.48 -0.03 (-0.04%) As of 08/4/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRVL vs. DVA, CHE, AMED, MD, AMN, CCRN, LH, DGX, APG, and ULSShould you be buying CorVel stock or one of its competitors? The main competitors of CorVel include DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), APi Group (APG), and UL Solutions (ULS). CorVel vs. Its Competitors DaVita Chemed Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Labcorp Quest Diagnostics APi Group UL Solutions CorVel (NASDAQ:CRVL) and DaVita (NYSE:DVA) are both health care services companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership. Which has better earnings and valuation, CRVL or DVA? DaVita has higher revenue and earnings than CorVel. DaVita is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCorVel$895.59M4.97$95.17M$1.8447.02DaVita$12.82B0.82$936.34M$10.0913.84 Which has more risk & volatility, CRVL or DVA? CorVel has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, DaVita has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Does the media favor CRVL or DVA? In the previous week, DaVita had 11 more articles in the media than CorVel. MarketBeat recorded 15 mentions for DaVita and 4 mentions for CorVel. DaVita's average media sentiment score of 0.92 beat CorVel's score of 0.75 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 9 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is CRVL or DVA more profitable? CorVel has a net margin of 10.63% compared to DaVita's net margin of 6.63%. DaVita's return on equity of 176.11% beat CorVel's return on equity.Company Net Margins Return on Equity Return on Assets CorVel10.63% 32.55% 18.22% DaVita 6.63%176.11%4.66% Do analysts rate CRVL or DVA? DaVita has a consensus price target of $167.40, suggesting a potential upside of 19.86%. Given DaVita's stronger consensus rating and higher probable upside, analysts plainly believe DaVita is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00DaVita 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders & institutionals have more ownership in CRVL or DVA? 51.4% of CorVel shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 44.6% of CorVel shares are held by insiders. Comparatively, 2.0% of DaVita shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryDaVita beats CorVel on 11 of the 16 factors compared between the two stocks. Get CorVel News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRVL vs. The Competition Export to ExcelMetricCorVelBUSINESS SVCS IndustryBusiness SectorNASDAQ ExchangeMarket Cap$4.46B$5.92B$14.79B$9.35BDividend YieldN/A3.13%2.85%4.15%P/E Ratio47.1124.2824.7024.41Price / Sales4.971.9165.39101.03Price / Cash35.7115.5525.4827.20Price / Book13.805.086.345.77Net Income$95.17M$155.75M$196.75M$264.99M7 Day Performance-2.25%-0.65%0.15%-0.68%1 Month Performance-15.86%-1.52%-0.78%7.08%1 Year Performance-10.62%50.02%34.34%23.80% CorVel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVLCorVel1.2631 of 5 stars$86.52-0.2%N/A-13.8%$4.46B$895.59M47.115,075DVADaVita4.4291 of 5 stars$145.37+0.1%$167.40+15.2%+0.1%$10.96B$12.82B14.4176,000CHEChemed4.9674 of 5 stars$464.55-1.3%$596.67+28.4%-28.3%$6.89B$2.43B22.6315,695Earnings ReportDividend IncreaseAMEDAmedisys2.9323 of 5 stars$96.91-1.1%$100.67+3.9%+0.4%$3.21B$2.35B35.7619,000Positive NewsEarnings ReportMDPediatrix Medical Group2.8598 of 5 stars$12.66+0.7%$16.67+31.6%+54.2%$1.08B$2.01B-12.534,305AMNAMN Healthcare Services4.2663 of 5 stars$19.71-0.5%$32.08+62.8%-72.7%$758.03M$2.98B-4.552,968Upcoming EarningsCCRNCross Country Healthcare3.5998 of 5 stars$13.81+1.5%$17.93+29.8%-24.8%$445.85M$1.34B-26.068,205Upcoming EarningsLHLabcorp4.6468 of 5 stars$261.15-1.4%$285.00+9.1%+11.8%$22.18B$13.01B28.8270,000Positive NewsDGXQuest Diagnostics4.7771 of 5 stars$167.84-0.4%$186.00+10.8%+15.0%$18.85B$9.87B20.1056,000Positive NewsAnalyst UpgradeAPGAPi Group3.1008 of 5 stars$34.74-1.2%$35.81+3.1%+55.3%$14.60B$7.14B113.2729,000Earnings ReportAnalyst ForecastAnalyst RevisionULSUL Solutions2.513 of 5 stars$70.09-0.3%$69.43-0.9%+43.4%$14.10B$2.87B41.9715,094Positive NewsShort Interest ↑ Related Companies and Tools Related Companies DVA Alternatives CHE Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives LH Alternatives DGX Alternatives APG Alternatives ULS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRVL) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorVel Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorVel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
